4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Neonatal Hyperbilirubinemia
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Specialist Answers
Question
1.What is the dose and schedule of Ibuprofen in the treatment of PDA? Are there any trials of Inj. Voveran in the treatment of PDA as it the only injectable alternative to Indomethacin in India? 2. Is there any modification to the Immunization schedule in a neonate who has undergone exchange transfusion? 3.What is the dose and duration of treatment. With Agaragar in a case of unconjugated Neonatal hyperbilirubinemia?
Answer
The dose for treatment of Ibuprofen for treatment of PDA is 10mg/kg loading dose followed by 5mg/kg 12hourly for 2 doses. At present, we are not aware of any trials of Inj Diclofenac in treatment of PDA. A child who has had exchange transfusion should not be given any vaccine for 6-8 weeks as the immunoglobulins present in the donated blood may interfere with the vaccination and lead to suboptimal response. Though agar alone is not recommended for treatment of unconjugated hyperbilirubinemia, it has been used in combination with photo-therapy in the dose of 1g/kgd orally in 4 divided doses till the serum bilirubin falls to a level where it does not require photo-therapy. However, its usefulness is still undetermined.
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us